
Vora 0.3mg Tablet
Marketer
Quintos Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Vora 0.3mg Tablet
DiaVora 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when diet and other antidiabetic agents prove insufficient, this medication should be administered immediately before meals. Dosage frequency is determined individually by your physician to optimize glycemic control. Abrupt discontinuation is unsafe; consult your doctor first to avoid potentially serious complications such as nephropathy and vision impairment. This medication is one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort, flatulence, anorexia, constipation, and diarrhea. Report persistent or bothersome side effects to your physician. While DiaVora 0.3mg tablets alone do not induce hypoglycemia, concomitant use with other antidiabetic medications, particularly insulin or sulfonylureas, increases this risk. Glucose should be used to treat hypoglycemic episodes; sucrose is ineffective. Prior to commencing treatment, inform your doctor of any hepatic or renal issues, or bowel inflammation (e.g., Crohn's disease or ulcerative colitis). This medication should be avoided during pregnancy and breastfeeding unless specifically approved by your physician. Complete disclosure of all medications is crucial for patient safety. Limit alcohol consumption while using this medication to reduce the hypoglycemia risk.
Primary Ingredients of Vora 0.3mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vora 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vora 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. The Vora 0.3mg Tablet should be taken on an empty stomach.
Common Side effects of Vora 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vora 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; refrain from chewing, crushing, or fracturing it. The Vora 0.3mg Tablet should be taken on an empty stomach.
How Vora 0.3mg Tablet works:
Vora 0.3mg tablets are used to manage diabetes. They work by blocking enzymes in the intestines that digest complex carbohydrates into glucose. This action helps keep blood sugar from spiking after eating.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Vora 0.3mg Tablet is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
The use of Vora 0.3mg Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vora 0.3mg Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vora 0.3mg Tablet.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vora 0.3mg Tablet. Dosage modification for Vora 0.3mg Tablet may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Vora tablets cautiously. Dosage modification of 0.3mg Vora tablets may be necessary. Physician consultation is advised.
What if you forget to take Vora 0.3mg Tablet :
Omit any missed Vora 0.3mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vora 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
